| Literature DB >> 28860265 |
Bram Rochwerg1, Laurent Brochard2,3, Mark W Elliott4, Dean Hess5, Nicholas S Hill6, Stefano Nava7, Paolo Navalesi8, Massimo Antonelli9, Jan Brozek1, Giorgio Conti9, Miquel Ferrer10, Kalpalatha Guntupalli11, Samir Jaber12, Sean Keenan13,14, Jordi Mancebo15, Sangeeta Mehta16, Suhail Raoof17,18.
Abstract
Noninvasive mechanical ventilation (NIV) is widely used in the acute care setting for acute respiratory failure (ARF) across a variety of aetiologies. This document provides European Respiratory Society/American Thoracic Society recommendations for the clinical application of NIV based on the most current literature.The guideline committee was composed of clinicians, methodologists and experts in the field of NIV. The committee developed recommendations based on the GRADE (Grading, Recommendation, Assessment, Development and Evaluation) methodology for each actionable question. The GRADE Evidence to Decision framework in the guideline development tool was used to generate recommendations. A number of topics were addressed using technical summaries without recommendations and these are discussed in the supplementary material.This guideline committee developed recommendations for 11 actionable questions in a PICO (population-intervention-comparison-outcome) format, all addressing the use of NIV for various aetiologies of ARF. The specific conditions where recommendations were made include exacerbation of chronic obstructive pulmonary disease, cardiogenic pulmonary oedema, de novo hypoxaemic respiratory failure, immunocompromised patients, chest trauma, palliation, post-operative care, weaning and post-extubation.This document summarises the current state of knowledge regarding the role of NIV in ARF. Evidence-based recommendations provide guidance to relevant stakeholders.Entities:
Mesh:
Year: 2017 PMID: 28860265 DOI: 10.1183/13993003.02426-2016
Source DB: PubMed Journal: Eur Respir J ISSN: 0903-1936 Impact factor: 16.671